Abvc Biopharma Inc
(ABVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -210 | N/A | -10,354 | -10,110 | -3,501 |
| Accounts receivable | N/A | N/A | N/A | N/A | -550 |
| Accounts payable and accrued liabilities | -18 | N/A | 11 | N/A | -300 |
| Other Working Capital | -15 | N/A | 6,193 | 9,681 | 2,627 |
| Other Operating Activity | 18 | 0 | 886 | 0 | 850 |
| Operating Cash Flow | $-225 | $N/A | $-3,263 | $-429 | $-874 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 2,050 | N/A | N/A |
| Other Financing Activity | 70 | 0 | 303 | 307 | 303 |
| Financing Cash Flow | $70 | $N/A | $2,353 | $307 | $303 |
| Beginning Cash Position | 174 | N/A | 995 | 995 | 995 |
| End Cash Position | 19 | N/A | 85 | 873 | 424 |
| Net Cash Flow | $-155 | $N/A | $-910 | $-122 | $-571 |
| Free Cash Flow | |||||
| Operating Cash Flow | -225 | N/A | -3,263 | -429 | -874 |
| Free Cash Flow | -225 | 0 | -3,263 | -429 | -874 |